GLP-1 medications provide gradual, sustainable results rather than instant changes
First, deficiency is common in gut disease chronic enteropathy and exocrine pancreatic insufficiency impair absorption, so cobalamin must be replaced
While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct
Their mechanisms of action arent always clearly defined
Another mitochondria-targeting drug, dithiol a-lipoic acid, demonstrated renoprotective benefits in an animal model of hypertension and renal illness
The results revealed that 12-week treatment with liraglutide led to significant improvements in intrinsic connectivity within the default mode network, as assessed by resting-state fMRI